Special Issue "Molecular Biomarkers and Precision Medicine for Alzheimer"
Deadline for manuscript submissions: closed (30 March 2022) | Viewed by 12216
Interests: neurodegeneration; cognitive neuroscience; PET/CT; molecular imaging; neuroimaging
Special Issues, Collections and Topics in MDPI journals
The diagnosis of Alzheimer’s disease (AD) is particularly challenging in the prodromal stages, when neuropathological changes might be present but symptoms are still mild, and in atypical clinical presentations in which the differential diagnosis between AD and other neurodegenerative dementia could be difficult due to overlapping symptoms.
It is therefore particularly important to identify potential biomarkers that can be used in the early detection of AD, i.e., before clinical signs appear, as well as to distinguish between AD and other types of dementia.
In this Special Issue, the current knowledge as well as future perspectives on the role of biomarkers in screening and differential diagnosis of Alzheimer’s disease will be discussed.
In particular, papers investigating the role of current and future CSF and blood biomarkers, genetic factors involved in cognitive decline, and molecular imaging biomarkers are requested.
Prof. Valentina Bessi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Alzheimer’s disease